Search filters

List of works by Jason R Westin

A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma

scientific article published on 09 December 2020

A clinician's guide to double hit lymphomas.

scientific article published on 22 December 2014

A phase 1 trial of alisertib and romidepsin for relapsed/refractory aggressive B-cell and T-cell lymphomas

scientific article published on 09 May 2019

A rare case of methotrexate and primaquine co-administration in a mantle cell lymphoma patient

scientific article published on 20 May 2019

A single case of rosai-dorfman disease marked by pathologic fractures, kidney failure, and liver cirrhosis treated with single-agent cladribine

scientific article published on 29 October 2014

Accelerated therapeutic progress in diffuse large B cell lymphoma

scientific article published on 28 December 2013

Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy

scientific article published on 01 September 2020

Autologous Stem Cell Transplantation for Large B-cell Lymphoma with Secondary Central Nervous System Involvement

Autologous stem cell transplantation for untreated transformed indolent B-cell lymphoma in first remission: an international, multi-centre propensity-score-matched study

scientific article published on 16 October 2020

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

scientific article published on 10 December 2017

Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma

scientific article published on 5 March 2015

Beyond R-CHOP and the IPI in large-cell lymphoma: molecular markers as an opportunity for stratification

scientific article published on October 2009

Bone mineral density screening should be routine in lymphoma patients

scientific article published on 01 April 2014

Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma

scientific article published on 01 July 2020

Busting robustness: using cancer's greatest strength to our advantage

scientific article

CAR T-Cells

scientific article published on 01 January 2020

Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas

scientific article published on 05 October 2020

Chimeric antigen receptor T-cell therapy - assessment and management of toxicities.

scientific article

Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma

scientific article published on 20 August 2018

Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphoma

scientific article published on 01 August 2020

Clinical efficacy of anakinra to mitigate CAR T-cell therapy-associated toxicity in large B-cell lymphoma

scientific article published on 01 July 2020

Clinical implications of positron emission tomography-negative residual computed tomography masses after chemotherapy for diffuse large B-cell lymphoma ⬇️

scientific article published on 07 May 2013

Clinicopathological characteristics, outcomes and pattern of mutations in patients with follicular lymphoma who progressed on Bruton tyrosine kinase inhibitors.

scientific article

Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study

scientific article

Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden

scientific article published on 14 August 2018

Could treatment with R-HCVAD/R-MA as compared to R- CHOP truly result in improved outcomes for patients with high-risk diffuse large B cell lymphoma? - Response to Landsburg et al.

scientific article

De novo CD5+ diffuse large B-cell lymphoma, NOS: clinical characteristics and outcomes in rituximab era

scientific article published on 18 September 2019

De novo CD5+ diffuse large B-cell lymphoma: a distinct subset with adverse features, poor failure-free survival and outcome with conventional therapy

scientific article published in January 2010

Deeper Insights Into Vanishing Bile Duct Syndrome in Lymphoma: A Perplexing Entity

scientific article published on 27 February 2016

Diffuse large B-cell lymphoma in very elderly patients over 80 years old: Incorporating consolidative radiation therapy into management decisions.

scientific article published on 22 April 2017

Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma

scientific article

Dose-Adjusted EPOCH-R and Mid-Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondary CNS Involvement.

scientific article published on 9 August 2016

Double hit lymphoma: the MD Anderson Cancer Center clinical experience.

scientific article

Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review

scientific article

Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction

scientific article published on 04 July 2019

Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients

scientific article published on 02 April 2020

Emerging Treatment Strategies for Primary Breast Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue

scientific article published on 03 January 2019

Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphoma

scientific article published on 18 May 2017

Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA

scientific article published on 22 July 2021

Experience with HSP90 inhibitor AUY922 in patients with relapsed or refractory non-Hodgkin lymphoma

scientific article published on 27 March 2015

Factors influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD Anderson Cancer Center in the rituximab era

scientific article published on 22 January 2016

Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma

scientific article published on 01 May 2019

Four-year follow-up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL)

scientific article published on 22 May 2018

Frontline antibiotic therapy for early-stage Helicobacter pylori-negative gastric MALT lymphoma

scientific article published on 06 March 2019

Gastrointestinal Adverse Events Observed After Chimeric Antigen Receptor T-Cell Therapy

scientific article published on 01 October 2019

Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL

scientific article published on 01 March 2020

Hematology oncology practice in the Asia-Pacific APHCON survey results from the 6th international hematologic malignancies conference: bridging the gap 2015, Beijing, China

scientific article published on 23 February 2017

Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma

scientific article published on 30 July 2020

High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study

scientific article published on 24 March 2017

Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy

scientific article published on 10 September 2018

Hodgkin lymphoma untreated for six years presenting with tracheoesophageal fistula

scientific article

ICU Resource Utilization in Critically Ill Patients Following Chimeric Antigen Receptor T-Cell Therapy

scientific article published on 12 June 2020

Ibrutinib and lenalidomide: when 1+1 = >2

scientific article published on 01 September 2019

Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial

scientific article published on 27 November 2015

Imaging Surveillance of Limited-stage Classic Hodgkin Lymphoma Patients After PET-CT-documented First Remission

scientific article published on 20 February 2020

Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL

scientific article published on 11 February 2019

Impact of Donor Type and Melphalan Dose on Allogeneic Transplantation Outcomes for Patients with Lymphoma

scientific article published on 11 February 2019

Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysis.

scientific article published on 22 June 2018

Impact of maintenance rituximab in patients with de novo transformed indolent B cell lymphoma

scientific article published on 06 July 2020

Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma

scientific article published on 4 August 2017

Integrating precision medicine through evaluation of cell of origin in treatment planning for diffuse large B-cell lymphoma

scientific article published on 16 May 2019

It's about time: lessons for solid tumors from chronic myelogenous leukemia therapy

scientific article

Lenalidomide plus rituximab (R2 ) in previously untreated marginal zone lymphoma: subgroup analysis and long-term follow-up of an open-label phase 2 trial

scientific article published on 28 March 2019

Long Term Follow-Up of Lenalidomide and Rituximab as Initial Treatment of Follicular Lymphoma

scientific article published on 15 September 2020

Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With R-CHOP.

scientific article

Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphoma.

scientific article published on 28 June 2016

Maternal and Fetal Outcomes After Therapy for Hodgkin or Non-Hodgkin Lymphoma Diagnosed During Pregnancy.

scientific article

Multimodality imaging of Epstein-Barr virus-associated inflammatory pseudotumor-like follicular dendritic cell tumor of the spleen: case report and literature review

scientific article published on 07 January 2015

Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma

scientific article published on 12 February 2019

Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy

scientific article published on 05 November 2020

Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study

scientific article published on 03 August 2017

Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma

scientific article published on 08 July 2014

Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma

scientific article published on 01 February 2020

Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes.

scientific article

Phase II Study of Bortezomib in Combination with Cyclophosphamide and Rituximab for Relapsed or Refractory Mantle Cell Lymphoma

scientific article

Phase-I and randomized phase-II trial of panobinostat in combination with ICE (ifosfamide, carboplatin, etoposide) in relapsed or refractory classical Hodgkin lymphoma.

scientific article published on 9 August 2017

Positron emission tomography-computed tomography predictors of progression after DA-R-EPOCH for PMBCL

scientific article published on 01 June 2018

Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphoma

scientific article published on 10 October 2019

Preclinical efficacy and biological effects of the oral proteasome inhibitor ixazomib in diffuse large B-cell lymphoma

scientific article published on 21 August 2017

Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma

scientific article published on May 2015

Pretreatment SUVmax may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FL

scientific article published on 23 January 2020

Primary Bone Lymphoma Exhibits a Favorable Prognosis and Distinct Gene Expression Signatures Resembling Diffuse Large B-Cell Lymphoma Derived From Centrocytes in the Germinal Center

scientific article published on 16 August 2017

Primary CNS lymphoma commonly expresses immune response biomarkers

scientific article published on 01 January 2020

Primary breast diffuse large B-cell lymphoma: treatment strategies and patterns of failure<sup/>

scientific article published on 26 April 2018

Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum β2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic model.

scientific article published on 22 July 2016

Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma

scientific article published on October 2013

R-CHOP every 21 days for diffuse large B-cell lymphoma: still the standard of care?

scientific article

Radiation Therapy as an Effective Salvage Strategy for Secondary CNS Lymphoma.

scientific article published on 6 January 2018

Radiation therapy for salivary gland MALT lymphoma: ultra-low dose treatment achieves encouraging early outcomes and spares salivary function

scientific article published on 02 August 2019

Radiation therapy improves survival in patients with testicular diffuse large B-cell lymphoma.

scientific article published on 9 May 2017

Reply to J. Wang et al

scientific article published on 12 February 2019

Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center

scientific article

Rosai-Dorfman Disease: The MD Anderson Cancer Center Experience

scientific article published on 04 July 2019

Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial

scientific article

Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial

scientific article

Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography

scientific article published on May 2015

Stage I Non-Hodgkin Lymphoma: difference in survival outcome by primary extranodal site of involvement

scientific article published on 05 July 2018

Stage I non-Hodgkin lymphoma: no plateau in disease-specific survival ?

scientific article published on 08 January 2019

Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

scientific article published on 13 May 2020

Status of PI3K/Akt/mTOR pathway inhibitors in lymphoma

scientific article

Steroid-Refractory Acute GVHD: Predictors and Outcomes.

scientific article published on 3 November 2011

Strategic therapeutic targeting to overcome venetoclax resistance in aggressive B-cell lymphomas.

scientific article published on 17 April 2018

Targetable genetic alterations of () drive immunoglobulin expression in diffuse large B cell lymphoma

scientific article published on 01 June 2019

The Other Side of CAR T-Cell Therapy: Cytokine Release Syndrome, Neurologic Toxicity, and Financial Burden

scientific article published on 01 January 2019

The risk of central nervous system relapses in patients with peripheral T-cell lymphoma

scientific article published on 14 March 2018

The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.

scientific article

Therapy of newly diagnosed follicular lymphoma ⬇️

scientific article published on December 11, 2012

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

scientific article published on 01 December 2018

Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion

scientific article published on 01 July 2019

Tonic B-cell receptor signaling in diffuse large B-cell lymphoma.

scientific article published on 23 June 2017

Treatment of chronic myelogenous leukemia as a paradigm for solid tumors: how targeted agents in newly diagnosed disease transformed outcomes

scientific article published on January 2012

Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma

scientific article published on 3 April 2017

Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma

scientific article published on 21 February 2018

Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma

scientific article published on 19 March 2019

University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCL.

scientific article

Vive la résistance: stem cells in mantle cell lymphoma

scientific article published on 04 April 2011

What to Do With Success? The Optimist's Creed in Relapsed Hodgkin Lymphoma

scientific article published on 8 June 2016

Why R-CHOP + X is not enough: lessons learned and next steps in the mission to improve frontline therapy for diffuse large B-cell lymphoma

scientific article published on 06 January 2021

Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial

scientific article published on 29 December 2012

Paulina is supported by:

About Paulina

Help